Elaine Boyd

5.7k total citations · 2 hit papers
9 papers, 4.2k citations indexed

About

Elaine Boyd is a scholar working on Genetics, Hematology and Rheumatology. According to data from OpenAlex, Elaine Boyd has authored 9 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 5 papers in Hematology and 4 papers in Rheumatology. Recurrent topics in Elaine Boyd's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Eosinophilic Disorders and Syndromes (4 papers). Elaine Boyd is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Eosinophilic Disorders and Syndromes (4 papers). Elaine Boyd collaborates with scholars based in United Kingdom and United States. Elaine Boyd's co-authors include Anthony J. Bench, Clare East, Peter J. Campbell, Linda M. Scott, George S. Vassiliou, E. Joanna Baxter, S Swanton, Nasios Fourouclas, Natasha Joan Curtin and Mike Scott and has published in prestigious journals such as The Lancet, Blood and British Journal of Haematology.

In The Last Decade

Elaine Boyd

9 papers receiving 4.1k citations

Hit Papers

Acquired mutation of the tyrosine kinase JAK2 in human my... 2005 2026 2012 2019 2005 2005 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
    2005 2.6k citations E. Joanna Baxter, Linda M. Scott et al. The Lancet profile →
  2. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
    2005 846 citations E. Joanna Baxter, Linda M. Scott et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elaine Boyd United Kingdom 8 3.7k 2.4k 2.3k 1.6k 618 9 4.2k
Clare East United Kingdom 7 4.2k 1.1× 2.7k 1.1× 2.6k 1.1× 1.8k 1.1× 610 1.0× 14 4.7k
Nasios Fourouclas United Kingdom 7 3.1k 0.8× 2.1k 0.9× 1.9k 0.8× 1.3k 0.8× 601 1.0× 8 3.6k
Natasha Joan Curtin United Kingdom 5 3.0k 0.8× 2.0k 0.8× 1.8k 0.8× 1.3k 0.8× 578 0.9× 6 3.5k
Catherine Lacout France 22 3.3k 0.9× 2.6k 1.1× 2.2k 1.0× 1.3k 0.8× 740 1.2× 47 4.3k
S Swanton United Kingdom 8 3.1k 0.8× 2.2k 0.9× 1.9k 0.8× 1.3k 0.8× 594 1.0× 11 3.7k
Anthony J. Bench United Kingdom 26 4.9k 1.3× 3.6k 1.5× 3.3k 1.4× 2.0k 1.3× 779 1.3× 48 6.2k
Francesca Palandri Italy 30 2.2k 0.6× 2.4k 1.0× 653 0.3× 1.2k 0.8× 293 0.5× 180 3.2k
Sandra Moore United States 9 1.3k 0.3× 1.1k 0.5× 978 0.4× 445 0.3× 254 0.4× 11 1.7k
Eric Bleickardt United States 19 2.4k 0.7× 3.3k 1.4× 763 0.3× 1.6k 1.0× 967 1.6× 40 4.0k
Ron Paquette United States 12 1.2k 0.3× 1.8k 0.7× 540 0.2× 625 0.4× 390 0.6× 23 2.2k

Countries citing papers authored by Elaine Boyd

Since Specialization
Citations

This map shows the geographic impact of Elaine Boyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elaine Boyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elaine Boyd more than expected).

Fields of papers citing papers by Elaine Boyd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elaine Boyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elaine Boyd. The network helps show where Elaine Boyd may publish in the future.

Co-authorship network of co-authors of Elaine Boyd

This figure shows the co-authorship network connecting the top 25 collaborators of Elaine Boyd. A scholar is included among the top collaborators of Elaine Boyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elaine Boyd. Elaine Boyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Gablasová, Dana, Václav Březina, Tony McEnery, & Elaine Boyd. (2015). Epistemic Stance in Spoken L2 English: The Effect of Task and Speaker Style. Applied Linguistics. 38(5). 613–637. 60 indexed citations
2.
Boyd, Elaine, Anthony J. Bench, Mars B. van ’t Veer, et al.. (2011). High resolution melting analysis for detection of BRAF exon 15 mutations in hairy cell leukaemia and other lymphoid malignancies. British Journal of Haematology. 155(5). 609–612. 55 indexed citations
3.
Boyd, Elaine, Anthony J. Bench, Shubha Anand, et al.. (2010). Clinical utility of routine MPL exon 10 analysis in the diagnosis of essential thrombocythaemia and primary myelofibrosis. British Journal of Haematology. 149(2). 250–257. 82 indexed citations
4.
Beer, Philip, Amy V. Jones, Anthony J. Bench, et al.. (2009). Clonal diversity in the myeloproliferative neoplasms: independent origins of genetically distinct clones. British Journal of Haematology. 144(6). 904–908. 57 indexed citations
5.
Happerfield, Lisa, Gary McIntosh, Mark Rees, et al.. (2009). Phospho‐STAT5 and phospho‐Akt expression in chronic myeloproliferative neoplasms. British Journal of Haematology. 147(4). 495–506. 56 indexed citations
6.
Campbell, Peter J., Linda M. Scott, Georgina Buck, et al.. (2005). Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study. The Lancet. 366(9501). 1945–1953. 473 indexed citations
7.
Baxter, E. Joanna, Linda M. Scott, Peter J. Campbell, et al.. (2005). Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. The Lancet. 365(9464). 1054–1061. 2554 indexed citations breakdown →
8.
Green, Anthony R., Peter J. Campbell, Linda M. Scott, et al.. (2005). JAK2 V617F Mutation Identifies a Biologically Distinct Subtype of Essential Thrombocythemia Which Resembles Polycythemia Vera.. Blood. 106(11). 253–253. 6 indexed citations
9.
Baxter, E. Joanna, Linda M. Scott, Peter J. Campbell, et al.. (2005). Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. The Lancet. 365(9464). 1054–1061. 846 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clare East Breakdown of academic impact, for papers by Nasios Fourouclas Breakdown of academic impact, for papers by Natasha Joan Curtin Breakdown of academic impact, for papers by Catherine Lacout Breakdown of academic impact, for papers by S Swanton Breakdown of academic impact, for papers by Anthony J. Bench Breakdown of academic impact, for papers by Francesca Palandri Breakdown of academic impact, for papers by Sandra Moore Breakdown of academic impact, for papers by Eric Bleickardt Breakdown of academic impact, for papers by Ron Paquette
Rankless by CCL
2026